Pain
FDA approves first new fibromyalgia therapy in over 15 years
August 18, 2025Medical Communications, Research and Development Pain, Tonix Pharmaceutical, US Food and Drug Administration, chronic pain, clinical trial, fibromyalgia
The US Food and Drug Administration (FDA) has approved Tonix Pharmaceutical’s Tonmya (cyclobenzaprine hydrochloric acid) for the treatment of fibromyalgia …
Universal Quantum partners with Open Quantum Institute to tackle endometriosis with new technology
July 29, 2025Medical Communications, Research and Development Open Quantum Institute, Pain, Reproductive health, UN Sustainable Development Goals, United Nations, Universal Quantum, endometriosis, women's health
Based in Brighton, UK, Universal Quantum has joined the Open Quantum Institute (OQI) to explore how quantum computing could revolutionise …
The Problem of Endometriosis in the UK
July 7, 2025Research and Development NHS, Obstetrics & Gynaecology, Pain, Reproductive health, Theramex, endometriosis, gynaecology
When did we decide it was an acceptable condition of womanhood in the UK to live with chronic pain?
PharmNovo submits CTA for non-addictive neuropathic pain therapeutic
July 1, 2025Medical Communications, Research and Development Clinical Trial Application (CTA), Neurology, Pain, PharmNovo, chronic cough, clinical trials, migraine, neuropathic pain, opioid use disorder, opioid withdrawal syndrome
Swedish biotech PharmNovo has submitted a clinical trial application (CTA) to the Spanish health authorities for its lead candidate PN6047, …
NMD Pharma’s Charcot-Marie-Tooth disease treatment granted ODD by FDA
January 6, 2025CMT, FDA, NMD Pharma, Orphan Drugs, Pain, nervous system, research and development
Biotech company NMD Pharma has announced that the US Food and Drug Association (FDA) have granted its Charcot-Marie-Tooth (CMT) disease …
Spinal cord stimulator with AI technology receives CE Mark certification
November 13, 2024Research and Development AI, EU, Nevro, Pain, spinal cord stimulation
The HFC iQ, a personalised spinal cord stimulation (SCS) system developed by Nevro that leverages AI technology to manage chronic …
Theramex receives recommendation for YSELTY in Scotland
November 11, 2024Research and Development Pain, Reproductive health, appproval, tumours, women's health
Theramex, a dedicated women’s health company, have announced that the Scottish Medicines Consortium (SMC) have recommended YSELTY (linzagolix) for the …
Latest content
Five Facts about cardiovascular disease
Artificial hearts: a century of innovation
